Jerman

Index
Globenewswire

Miltenyi Biomedicine Memaparkan Analisis Primer dari Uji Klinis DALY 2-EU yang Penting untuk Limfoma Sel B Besar yang Kambuh/refraktori Pada Lini Kedua pada Pertemuan Tahunan American Society of Haematology (ASH) ke-67

Globenewswire

Miltenyi Biomedicine Presents Primary Analysis of the Pivotal DALY 2-EU Trial for Second-line Relapsed/refractory Large B-cell Lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Globenewswire

UPDATE -- Black Forest Labs Announces Series B Investment to Accelerate Frontier Visual Intelligence

Globenewswire

Black Forest Labs Announces Series B Investment to Accelerate Frontier Visual Intelligence

Globenewswire

New Study Reveals $11.28M Annual Opportunity for Industrial Companies to Boost Competitiveness by Modernizing Closed Automation Systems

Globenewswire

GetYourGuide Unveils 2026 Hidden Trends List: Birdwatching, Coffee Culture and Skill-Seeking Set to Drive Experience-Led Trips

Globenewswire

From Wind Tunnels to Space: Vacuum for Aerospace Research

Globenewswire

Heidelberg Engineering Joins the Collaborative Community on Ophthalmic Innovation (CCOI) Through EssilorLuxottica’s Vision Architect Membership

Globenewswire

CNH Brands win 2026 Farm Machine of the Year Awards

Globenewswire

New Holland wins ‘Best Specialized’ at Tractor of the Year 2026 Awards

Globenewswire

LEAG and Fluence to Build the Largest Battery Storage Project in Europe with a Capacity of 4 GWh

Globenewswire

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Globenewswire

Boehringer Ingelheim Acquires License from Kyowa Kirin Aimed at Developing a Novel Treatment for Patients with Autoimmune Diseases

Globenewswire

ESPAS and Steinehelden Use Descartes’ Solution to Optimize Ecommerce Productivity by 500% While Supporting Special Needs of Workers

Globenewswire

RIB Software Partners with Microsoft to Accelerate AI in Construction

Globenewswire

JASCAYD® (nerandomilast) Approved in China for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Globenewswire

Boehringer’s Zongertinib Demonstrated a 77% Objective Response Rate in Treatment-naïve Patients with Advanced HER2 (ERBB2)-mutant NSCLC

Globenewswire

Boehringer Ingelheim Advances Cancer Antibody-drug Conjugate Portfolio with Asset from AimedBio

Globenewswire

From Diversity to Impact: The Power of Diversity Funding Facility Identifies Priority Opportunity Crops for Investment

Globenewswire

U.S. FDA Approves Boehringer’s JASCAYD® (nerandomilast tablets) as First New Treatment Option for Adults with IPF in Over a Decade

Globenewswire

Rentschler Biopharma Further Expands its Services in Japan and South Korea and will Attend BioProcess International Asia

Globenewswire

Automotive: BYD Marks Impressive Presence at IAA Mobility 2025 in Munich

Globenewswire

BYD’s Stella Li Highlights New Models, European Factory and Innovation at IAA Mobility 2025

Globenewswire

21X Rings the Bell as Trading Starts on the World’s First Blockchain-based Exchange for Tokenized Securities and Stablecoins

Globenewswire

Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season